UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025350
Receipt number R000029182
Scientific Title Efficacy of Relationship Developmental Intervention program in the treatment of Autism Spectrum Disorder
Date of disclosure of the study information 2022/04/01
Last modified on 2016/12/21 15:20:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Relationship Developmental Intervention program in the treatment of Autism Spectrum Disorder

Acronym

Efficacy of Relationship Developmental Intervention program

Scientific Title

Efficacy of Relationship Developmental Intervention program in the treatment of Autism Spectrum Disorder

Scientific Title:Acronym

Efficacy of Relationship Developmental Intervention program

Region

Japan


Condition

Condition

Autism Spectrum Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To detect the efficacy of Relationship Developmental Intervention

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Vineland Adaptive Behavior Scales, Second Edition(1 and 2 year after Intervention)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Relationship Developmental Intervention for 1 year

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 years-old <=

Age-upper limit

6 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Diagnosed as Autism Spectrum Disorder using ADOS-2, ADI-R, PARS-TR, DSM-5 by research team.
2.Patient who have not experienced RDI.

Key exclusion criteria

1.IQ scores less than 70
2.Major physical problems, significan sensory or motor impairment
3.Apparent genetic disorder
4.History of a serious head injury and/or nuerologic disease
5.Seizures of past history

Target sample size

22


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Manabu Takaki

Organization

Okayama University Graduate school of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Department of Neuropsychiatry

Zip code


Address

2-5-1, Shikata-cyo, kitaku, Okayama Japan, Zip 700-8558

TEL

0862357242

Email

manabuta@cc.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makiko Kishimoto

Organization

Okayama University Graduate school of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Department of Neuropsychiatry

Zip code


Address

2-5-1, Shikata-cyo, kitaku, Okayama Japan, Zip 700-8558

TEL

0862357242

Homepage URL


Email

kiko973@hb.tp1.jp


Sponsor or person

Institute

Okayama University Graduate school of Medicine, Dentistry and Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

The Foundation of Growth Science

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2019 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 12 Month 21 Day

Last modified on

2016 Year 12 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029182